Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms: HELP
Articles by Traian Dumitrascu
Based on 19 articles published since 2010
(Why 19 articles?)

Between 2010 and 2020, T. Dumitrascu wrote the following 19 articles about Pancreatic Neoplasms.
+ Citations + Abstracts
1 Editorial [Pancreatoduodenectomy--past, present and future]. 2011

Popescu, I / Dumitraşcu, T. · ·Chirurgia (Bucur) · Pubmed #21853734.

ABSTRACT: Pancreatico-duodenectomy represents one of the most important and complex surgical digestive procedure. Although rarely performed in the past, nowadays has become a routine surgery. Moreover, postoperative mortality significantly decreased (from over 30% to less than 5%), while the number of severe, life-threatening complications were reduced. This outcome was possible due to technical innovations acquired in time, and also due to a better per operative management of these patients, in tertiary surgical centers, with experienced operative teams. Some modifications of the standard procedure of resection, like posterior or artery first approach contributed to better results, facilitating en-block resection of the portal/ superior mesenteric vein, where needed. Moreover, posterior approach facilitates complete mesopancreas excision, involved in local recurrence after resection of pancreatic head adenocarcinoma. Regarding reconstruction after pancreaticoduodenectomy, there is no optimal type of anastomosis (pancreatico-gastrostomy vs pancreatico-jejunostomy), results being related mostly with the expertise of the operative team, as like the postoperative pancreatic fistula rate. Future studies are deemed to look on the real clinical impact of the total mesopancreas excision in achieving negative resection margins, decreasing local recurrence and increasing the long-term survival of patients resected for pancreatic head cancer.

2 Review Is Hepatitis B Virus a Player in Pancreatic Cancer? 2018

Dumitrascu, Traian / Pineau, Pascal. · ·Chirurgia (Bucur) · Pubmed #29981665.

ABSTRACT: Pancreatic cancer (i.e., pancreatic ductal adenocarcinoma, PDAC) is an important healthcare issue and a highly lethal disease. Thus, almost 80% of patients with PDAC will die within one year after diagnosis. Several factors including smoking, obesity, advanced age, diabetes mellitus and chronic pancreatitis have been associated with increased risk of PDAC. Hepatitis B virus (HBV) infection is also considered as a risk factor for PDAC development in some studies. However, the role of HBV infection in PDAC is poorly explored. The present paper reviews the current relevant literature exploring the impact of HBV infection in PDAC. Assessment of HBV infection impact in PDAC is challenging because its effects could be easily underestimated. Indeed, the role played by occult B infection (OBI) and intrinsic difficulties to detect HBV antigens or DNA in pancreatic tissue remains major limitations to further progress. To date a significant proportion of available literature suggests the potential oncogenic role of HBV in PDAC but experimental evidences remain scarce. Remarkably, it appears that HBV infection might influence some clinical and pathological features of patients with PDAC. Future researches to better define the role of HBV infection in developing PDAC are urgently needed.

3 Review What is the Value of Total Mesopancreas Excision in Pancreatic Ductal Adenocarcinoma? Current Evidence of the Literature. 2018

Popescu, Irinel / Dumitrascu, Traian. · ·Chirurgia (Bucur) · Pubmed #29981664.

ABSTRACT: Pancreatic ductal adenocarcinoma (PDAC) is a disease with a grim prognosis. Pancreatectomy represents the single hope for long-term survival in a patient with PDAC. Recurrence is a common event after curative-intent surgery for PDAC, mainly related to incomplete removal at the site of resection margins; medial/ superior mesenteric margins are the most often positive. The concept of total mesopancreas excision (TMpE) in PDAC was proposed in analogy to the concept of total mesorectal excision for rectal cancer, to better control loco-regional recurrence. This paper aims to discuss the current evidence for the value of TMpE in PDAC.

4 Review Total meso-pancreas excision: key point of resection in pancreatic head adenocarcinoma. 2011

Popescu, Irinel / Dumitrascu, Traian. ·Center of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Fundeni Street no. 258, 022328, Bucharest, Romania. irinel.popescu220@gmail.com ·Hepatogastroenterology · Pubmed #21510315.

ABSTRACT: Pancreatic head cancer is a disease with a dismal prognosis, even after curative intent surgery, Resection represents the only hope for long-term survival. The negative resection margins (R0 resection) represent a strong independent prognostic factor. Up to 80% of so-called curative resections are, in fact, non-curative (with microscopically positive margins). The area most involved in positive resection margins is the meso-pancreas. Thus, the local recurrence is up to 80% within one year after resection. The term meso-pancreas was recently proposed to emphasize this area's role in positive resection margins, local recurrence after pancreatoduodenectomy and prognosis. Total meso-pancreas excision is presumed to decrease the rate of R1 resection and improve survival and is facilitated by a posterior/artery first approach.

5 Article An Attempt to Build a National Prospective Electronic Database for Pancreaticoduodenectomies in Romania - Preliminary Results of the First Year Enrollment. 2018

Bartos, Adrian / Ionescu, Mihnea / Iancu, Cornel / Stroescu, Cezar / Zaharie, Florin / Brasoveanu, Vladislav / Hajjar, Nadim Al / Vasilescu, Catalin / Graur, Florin / Hutanu, Ionut / Mocan, Lucian / David, Leonard / Bodea, Raluca / Cacovean, Dan / Molnar, Geza / Furcea, Luminita / Alexandrescu, Sorin / Matei, Emil / Mitulescu, Gabriel / Ungureanu, Constantin / Tonea, Aurel / Zamfir, Radu / Popescu, Irinel / Dumitrascu, Traian. · ·Chirurgia (Bucur) · Pubmed #29981668.


6 Article One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma. 2018

Dumitrascu, Traian / Martiniuc, Alexandru / Brasoveanu, Vladislav / Stroescu, Cezar / David, Leonard / Dima, Simona / Stanciulea, Oana / Ionescu, Mihnea / Popescu, Irinel. · ·Chirurgia (Bucur) · Pubmed #29981667.


7 Article Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. 2018

Klompmaker, Sjors / van Hilst, Jony / Gerritsen, Sarah L / Adham, Mustapha / Teresa Albiol Quer, M / Bassi, Claudio / Berrevoet, Frederik / Boggi, Ugo / Busch, Olivier R / Cesaretti, Manuela / Dalla Valle, Raffaele / Darnis, Benjamin / De Pastena, Matteo / Del Chiaro, Marco / Grützmann, Robert / Diener, Markus K / Dumitrascu, Traian / Friess, Helmut / Ivanecz, Arpad / Karayiannakis, Anastasios / Fusai, Giuseppe K / Labori, Knut J / Lombardo, Carlo / López-Ben, Santiago / Mabrut, Jean-Yves / Niesen, Willem / Pardo, Fernando / Perinel, Julie / Popescu, Irinel / Roeyen, Geert / Sauvanet, Alain / Prasad, Raj / Sturesson, Christian / Lesurtel, Mickael / Kleeff, Jorg / Salvia, Roberto / Besselink, Marc G / Anonymous5490939. ·Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands. · Department of Digestive Surgery, E. Herriot Hospital, HCL, UCBL1, Lyon, France. · Department of Surgery, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain. · Department of Surgery, University of Verona, Verona, Italy. · Department of General and HPB Surgery, Ghent University Hospital, Ghent, Belgium. · Division of General and Transplant Surgery, University of Pisa, Pisa, Italy. · Department of HPB Surgery, Hôpital Beaujon, Clichy Cedex, France. · Hepato-Pancreato-Biliary Unit, Parma University Hospital, Parma, Italy. · Department of Surgery and Liver Transplantation, Croix-Rousse University Hospital, Hospices Civils de Lyon, University of Lyon I, Lyon, France. · Department of Clinical Science, Intervention and Technology, Karolinska University Hospital, Stockholm, Sweden. · Department of Surgery, University Hospital Erlangen, Erlangen, Germany. · Department of General, Visceral and Transplantation Surgery, Heidelberg University, Heidelberg, Germany. · Center of General Surgery and Liver Transplant, Fundeni Clinical Institute, Bucharest, Romania. · Department of Surgery, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany. · Department of Abdominal and General Surgery, University Medical Centre Maribor, Maribor, Slovenia. · Second Department of Surgery, Democritus University of Thrace, Alexandroupolis, Greece. · HPB Surgery and Liver Transplantation Unit, Royal Free Hospital, London, UK. · Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway. · Department of HPB and Transplant Surgery, Clínica Universidad de Navarra, Pamplona, Spain. · Department of Hepatobiliary, Endocrine and Transplantation Surgery, Antwerp University Hospital, Antwerp, Belgium. · Department of HPB and Transplant Services, National Health Service, Leeds, UK. · Department of Surgery, Skåne University Hospital, Lund, Sweden. · Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, Halle, Germany. · Department of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, the Netherlands. m.g.besselink@amc.nl. ·Ann Surg Oncol · Pubmed #29532342.

ABSTRACT: BACKGROUND: Western multicenter studies on distal pancreatectomy with celiac axis resection (DP-CAR), also known as the Appleby procedure, for locally advanced pancreatic cancer are lacking. We aimed to study overall survival, morbidity, mortality and the impact of preoperative hepatic artery embolization (PHAE). METHODS: Retrospective cohort study within the European-African Hepato-Pancreato-Biliary-Association, on DP-CAR between 1-1-2000 and 6-1-2016. Primary endpoint was overall survival. Secondary endpoints were radicality (R0-resection), 90-day mortality, major morbidity, and pancreatic fistulae (grade B/C). RESULTS: We included 68 patients from 20 hospitals in 12 countries. Postoperatively, 53% of patients had R0-resection, 25% major morbidity, 21% an ISGPS grade B/C pancreatic fistula, and 16% mortality. In total, 82% received (neo-)adjuvant chemotherapy and median overall survival in 62 patients with pancreatic ductal adenocarcinoma patients was 18 months (CI 10-37). We observed no impact of PHAE on ischemic complications. CONCLUSIONS: DP-CAR combined with chemotherapy for locally advanced pancreatic cancer is associated with acceptable overall survival. The 90-day mortality is too high and should be reduced. Future studies should investigate to what extent increasing surgical volume or better patient selection can improve outcomes.

8 Article Impact of Hepatitis B Virus on Clinicopathological Features and Outcomes After Resection for Pancreatic Adenocarcinoma. 2015

Dumitrascu, Traian / Pineau, Pascal / Dima, Simona / Stroescu, Cezar / Brasoveanu, Vladislav / Herlea, Vlad / Ionescu, Mihnea / Popescu, Irinel. ·Center of General Surgery and Liver Transplant, Fundeni Clinical Institute, Bucharest, Romania. · Nuclear Organization and Oncogene Unit, U993, Pasteur Institute, Paris, France. · Department of Pathology, Fundeni Clinical Institute, Bucharest, Romania. · Center of General Surgery and Liver Transplant, Fundeni Clinical Institute, Bucharest, Romania irinel.popescu220@gmail.com. ·Anticancer Res · Pubmed #26254417.

ABSTRACT: MATERIALS AND METHODS: According to HBV surface antigen seroreactivity, 343 patients were classified as having non-viral or HBV-related cases of PDAC. Clinicopathological data and outcomes were comparatively assessed between the groups. RESULTS: Chronic HBV infection was observed in 16 patients (4.5%). No significant differences between the HBV and non-viral cases of PDAC were observed. Tumor diameters (3.4 vs. 3.0, p=0.092) and stages at diagnosis (31 vs. 14% T1-T2, p=0.082) tended to differ between the groups, albeit without reaching significance. Completion of adjuvant therapy (63 vs. 54%, p=0.612), as well as median overall survival (15 vs. 17 months, p=0.346) was similar in the HBV and non-viral PDAC groups. CONCLUSION: HBV-positive and virus-free patients with PDAC generally shared the same demographic, clinical and pathological profiles. HBV did not appear to have a detrimental effect on either early or long-term outcomes after resection for PDAC. Future studies searching for occult infection might, however, shed a different light on the role of HBV in PDAC.

9 Article A posterior approach pancreaticoduodenectomy with portal vein resection in a large adenocarcinoma of the uncinate process of the pancreas - case report. 2015

Moldovan, S C / Dumitraşcu, T / Mensier, A / Desurmont, T / Dominguez, S / Cambier, N / Moldovan, A M / Gosset, P / Popescu, I / Anonymous2090831. · ·Chirurgia (Bucur) · Pubmed #26011839.

ABSTRACT: A portal vein invasion is no longer a contraindication for resection in pancreatic cancer, but increased morbidity and mortality rates can be encountered. Hereby it is presented the case of a patient diagnosed with a large adenocarcinoma of the uncinate process of the pancreas, who underwent aposterior approach pancreaticoduodenectomy, with en bloctang ential resection of the portal vein, and total mesopan creasexcision. A posterior approach allows a negative resection margins pancreaticoduodenectomy, with a good local control of the disease, despite the in creas.

10 Article Central pancreatectomy versus spleen-preserving distal pancreatectomy: a comparative analysis of early and late postoperative outcomes. 2012

Dumitrascu, Traian / Scarlat, Andra / Ionescu, Mihnea / Popescu, Irinel. ·Center of General Surgery and Liver Transplant, Fundeni Clinical Institute, Bucharest, Romania. ·Dig Surg · Pubmed #23128466.

ABSTRACT: BACKGROUND/AIM: The aim of the present study is to compare the postoperative and long-term outcomes of central pancreatectomy (CP) and spleen-preserving distal pancreatectomy (SPDP). METHODS: Clinical, pathological and long-term data were compared between 22 patients who underwent CP and 25 patients who underwent SPDP (2002-2012). RESULTS: The median length of resected pancreas was 8.5 cm in the SPDP group and 5 cm in the CP group (p < 0.001). The median estimated blood loss was significantly lower in the CP group (p = 0.019). Morbidity was 50% for CPs and 40% for SPDPs (p = 0.564). The rate of pancreatic fistulae was 36% for CPs and 40% for SPDPs (p = 0.530). The rate of new-onset diabetes was nil in the successful CP group and 16% in the SPDP group (p = 0.111). CONCLUSION: Morbidity and pancreatic fistula rates are not higher after CP when compared to SPDP. The loss of normal pancreatic tissue is significantly lower for CP, and thus there is potentially better preservation of the pancreatic endocrine functions. CP should be considered only in selected cases when preservation of the pancreas is of utmost importance, especially for lesions situated at the level of the pancreatic neck.

11 Article POSSUM, a potentially useful tool for prediction of morbidity in patients undergoing central pancreatectomy. 2012

Dumitraşcu, T / Barbu, S T / Ionescu, M / Popescu, I. ·Center of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania. traian.dumitrascu@srchirurgie.ro ·Chirurgia (Bucur) · Pubmed #23025110.

ABSTRACT: AIM: Central pancreatectomy is a pancreas-sparing alternative to standard pancreatic resections, and it is associated with substantial morbidity. The aim of the present study is to assess the utility of the POSSUM scoring system in the prediction of the postoperative complications after central pancreatectomy, which would help identify the patients who are at the highest risk of developing complications. METHODS: A retrospective analysis of 24 patients who underwent central pancreatectomies (2002-2010) was performed. The POSSUM score was calculated for each patient and was correlated with observed morbidity. RESULTS: The mean POSSUM score was 32, thus predicting morbidity in 9 out of 24 patients. This risk assessment proved to be quite accurate, as 13 patients (54%) actually developed postoperative complications (chi-squared = 3.2101, p = 0.073). The predictive value of the POSSUM was strongest for the < or = 20%, 60-80% and > or = 80% morbidity risk cohorts (O/E ratio 1). CONCLUSIONS: The identification of a scoring system to predict the development of severe complications after central pancreatectomy may stratify the patients' risk and lead to a tailored approach of this surgical procedure. Although POSSUM seems to predict morbidity after central pancreatectomy, further studies involving larger numbers of patients should be conducted to confirm this effect.

12 Article Dorsal pancreas agenesis and ductal adenocarcinoma: surgical implications of an extremely rare association. 2012

Dumitraşcu, T / Scarlat, A / Diaconescu, A / Ionescu, M. ·Center of General Surgery and Liver Transplant, Fundeni Clinical Institute, Bucharest, Romania. traian.dumitrascu@srchirurgie.ro ·Chirurgia (Bucur) · Pubmed #22844839.

ABSTRACT: It is presented the case of a 44-year-old woman with ductal adenocarcinoma of the pancreatic head with associated dorsal pancreas agenesis. In this case, curative intent surgery implies removal of the whole pancreas with its consequences--parental insulin requirement and exocrine pancreatic insufficiency. A review of the literature on the previously reported cases was performed.

13 Article Pathological characteristics and clinical specifications in gastroenteropancreatic neuroendocrine tumors: a study of 68 cases. 2012

Stoica-Mustafa, Elena / Pechianu, C / Iorgescu, Andreea / Hortopan, Monica / Dima, Simona Olimpia / Tomulescu, V / Dumitraşcu, T / Ungureanu, C / Andronesi, D / Popescu, I / Herlea, V. ·Department of Pathology, Fundeni Clinical Institute, Bucharest, Romania. ·Rom J Morphol Embryol · Pubmed #22732805.

ABSTRACT: INTRODUCTION: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a group of tumors, having their origin in cells of diffuse endocrine system, with particular clinical course, diagnosis and treatment. PATIENTS AND METHODS: In our study, were included 68 patients with neuroendocrine digestive tumors admitted, diagnosed and treated in Fundeni Clinical Institute, Bucharest, in the last ten years--2000-2010 (retrospective study). RESULTS: Thirty-three (49%) patients were males, 35 (51%) females, and the main age was 58.9 years. In 62 (90.3%) cases was possible to find the primary tumor. The examined tumors had different localizations: pancreas--32 (47.04%) cases (head--17 (24.99%) cases, and body and tail--15 (22.05%) cases), stomach--7 (10.29%) cases, small intestine--7 (10.29%) cases, 6 (8.82%) cases--unknown primary site (diagnosis was established on metastases), right colon--6 (8.82%) cases, liver--6 (8.82%) cases, rectum--2 (2.94%) cases, and retroperitoneum--2 (2.94%) cases. Microscopic examination revealed 59 (86.8%) malignant tumors and 9 (13.2%) benign tumors. Using WHO 2000 Classification, 28 cases of malignant tumors were well-differentiated neuroendocrine carcinomas, and 31 cases were poor differentiated neuroendocrine carcinomas. From malignant cases, 25 (42.3%) have distant metastases and 15 (25.9%) lymph node metastases. CONCLUSIONS: Cases of gastroenteropancreatic neuroendocrine tumors included in our study had clinical and histopathological features in correspondence with data from literature--slight predominance in women, predominance in 5th and 6th decades of life, the most frequent localizations were at pancreatic level--both head and body and tail, but the rarest were in colon and retroperitoneum. Most of the cases studied, were malignant tumors, from these more than a half were poor differentiated, and a quarter of them having lymph node or distant metastases.

14 Article An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma. 2012

Dima, Simona O / Tanase, Cristiana / Albulescu, Radu / Herlea, Vlad / Chivu-Economescu, Mihaela / Purnichescu-Purtan, Raluca / Dumitrascu, Traian / Duda, Dan G / Popescu, Irinel. ·Center of Digestive Disease and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania. ·Pancreas · Pubmed #22722257.

ABSTRACT: OBJECTIVES: We measured the serum concentration of a panel of inflammatory cytokines and evaluated their association with circulating proangiogenic biomarkers and with outcome in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: We collected serum samples from 36 patients with PDAC, 9 patients with chronic pancreatitis, and 22 healthy volunteers as a control. Inflammatory cytokines and proangiogenic biomarkers were measured using the multianalyte xMAP array and carcinoembryonic antigen (CEA) and carbohydrate 19-9 by immunoassay. RESULTS: Patients with PDAC had higher circulating levels of interleukin 6 (IL-6) than those of patients with pancreatitis or healthy individuals and higher levels of IL-10 and tumor necrosis factor α (TNF-α) compared with those of healthy individuals. In patients with PDAC, circulating IL-6, TNF-α, IL-1β, and IL-10 correlated with serum concentrations of vascular endothelial growth factor and basic fibroblast growth factor; circulating IL-6, IL-1β, and TNF-α correlated with carbohydrate 19-9; and IL-8, IL-10, and TNF-α correlated with CEA levels. Circulating IL-8, TNF-α, and CEA; tumor stage; and lymph node metastases were associated with a poor outcome. CONCLUSIONS: The results of this exploratory study indicate that inflammatory cytokines should be pursued as potential prognostic biomarkers as well as targets for therapy in larger studies in PDAC.

15 Article Risk factors for surgical complications after central pancreatectomy. 2012

Dumitrascu, Traian / Barbu, Sorin T / Purnichescu-Purtan, Raluca / Ionescu, Mihnea / Popescu, Irinel. ·Fundeni Clinical Institute, Bucharest, Romania. traian.dumitrascu@srchirurgie.ro ·Hepatogastroenterology · Pubmed #22353528.

ABSTRACT: BACKGROUND/AIMS: Central pancreatectomy is a pancreas-sparing alternative to standard pancreatic resections in selected cases. Although associated with high morbidity, the risk factors for surgical complications of this procedure are not yet defined. METHODOLOGY: The clinicopathological and perioperative data of 24 patients who underwent central pancreatectomies (2002-2010) were correlated with surgical complications. RESULTS: The overall morbidity rate was 54% (pancreatic fistula, 40%). In a univariate analysis, age over 40 years, body mass index ≥30kg/m2, smoking and American Society of Anesthesiologists III scores were significantly correlated with increased morbidity. In a multivariate analysis, a significant correlation with the development of complications was found for body mass index ≥30kg/m2 and age over 40 years. CONCLUSIONS: Certain patient-related factors (older age, obesity and smoking) appear to have a negative impact on early postoperative outcome after central pancreatectomy. For patients with these factors, an alternative distal pancreatectomy should be considered. Central pancreatectomy should be tailored not only to the pathology but also to the patient profile.

16 Article Central pancreatectomy for pancreatoblastoma in a 16-year-old girl. 2011

Dumitrascu, Traian / Stanciulea, Oana / Herlea, Vlad / Tomulescu, Victor / Ionescu, Mihnea. ·Center of General Surgery and Liver Transplantation, 022328 Bucharest, Romania. traian.dumitrascu@srchirurgie.ro ·J Pediatr Surg · Pubmed #21843703.

ABSTRACT: Long-term functional results after standard pancreatic resections are a major concern, especially in children. An alternative pancreas-sparing procedure (such as central pancreatectomy) should be taken into consideration whenever it is feasible, and a prolonged survival is expected. Pancreatoblastoma is an unusual malignant tumor in childhood. However, in initially resectable tumors, the 15-year survival is more than 80%. Thus, there is a potential role of a conservative pancreatic resection in successful treatment of pancreatoblastoma. The management in a case of a 16-year-old girl with a pancreatoblastoma in the body of pancreas is presented. Complete surgical resection by central pancreatectomy followed by chemotherapy led to a prolonged disease-free survival, with good functional results. Central pancreatectomy could be an alternative surgical technique in some selected cases of pancreatoblastoma, having the lowest incidence of postoperative exocrine and endocrine insufficiency rate and offering the best nutritional status.

17 Minor Total mesopancreas excision in pancreatic head adenocarcinoma: The same impact as total mesorectal excision in rectal carcinoma? Comment on article "surgical technique and results of total mesopancreas excision in pancreatic tumours" by Adham M and Singhirunnusorn J, Eur J Surg Oncol, 2012. 2012

Dumitrascu, T / Popescu, I. · ·Eur J Surg Oncol · Pubmed #22525857.

ABSTRACT: -- No abstract --

18 Minor [Central pancreatectomy--an alternative for surgical approach of the benign and low-malignant tumors of the pancreatic body in young patients]. 2011

Dumitraşcu, T / Dima, S. · ·Chirurgia (Bucur) · Pubmed #22165073.

ABSTRACT: -- No abstract --

19 Minor Posterior approach pancreaticoduodenectomy: does it really improve long-term survival in pancreatic head cancer? 2011

Dumitrascu, Traian / Popescu, Irinel. · ·JOP · Pubmed #21904079.

ABSTRACT: -- No abstract --